经皮膈神经电刺激预防有创机械通气患者呼吸机诱导膈肌功能障碍的效果
该单中心随机对照试验纳入2022年11月至2023年12月嘉兴市第一医院ICU收治的120例有创机械通气患者,随机分为对照组(ICU标准化护理)和观察组(加用经皮膈神经电刺激,强度10 U、脉冲频率40 Hz、刺激频率12次/min、每日1次30分钟、共5天)。最终分析对照组51例、观察组53例。观察组第5天膈肌增厚分数(DTF)高于对照组,动脉血氧分压更高、二氧化碳分压更低;观察组VIDD发生率15.09%(8/53)显著低于对照组37.25%(19/51),机械通气时间和ICU住院时间均显著缩短。
要点
- 经皮膈神经电刺激方案:强度10 U、脉冲频率40 Hz、刺激频率12次/min,每日1次30分钟,共5天,在ICU标准化护理基础上加用。
- 干预5天后观察组VIDD发生率15.09%(8/53)显著低于对照组37.25%(19/51),P<0.05。
- 观察组机械通气时间7.93±2.06天 vs 对照组8.77±1.76天,ICU住院时间9.64±2.35天 vs 11.01±2.01天,均P<0.05。
- 干预5天后观察组PaO2 100.72±15.75 mmHg vs 对照组93.62±15.54 mmHg,PaCO2 36.53±3.10 mmHg vs 37.69±2.02 mmHg,均P<0.05。
- DTF随时间逐渐升高,观察组变化更显著,存在时间效应(Ftime=105.975,P<0.001)、干预效应(Fintervention=7.378,P=0.008)和交互效应(Finteraction=3.322,P=0.038)。
适用人群与场景
- ICU收治的需有创机械通气患者,来自嘉兴市第一医院2022年11月至2023年12月收治人群。
处置流程与药物剂量
- 对照组给予ICU标准化护理干预,包括翻身拍背、抬高床头、按需吸痰、雾化吸入、口腔护理及气囊压力和胃潴留监测。
- 观察组在ICU标准化护理干预基础上加用经皮膈神经电刺激,刺激强度10 U、脉冲频率40 Hz、刺激频率12次/min,每日1次、每次30分钟,共5天。
研究设计与关键结果
- 单中心随机对照试验,纳入120例有创机械通气患者,脱落16例(脱落率13.33%),最终分析对照组51例、观察组53例。
- 两组性别、年龄、BMI、APACHE II评分、白蛋白、血红蛋白及疾病类型等基线特征无显著差异。
- DTF在两组均随干预时间逐渐升高:对照组第1、3、5天分别为(20.83±2.33)%、(21.92±1.27)%、(23.93±2.33)%;观察组分别为(20.89±1.96)%、(22.56±1.64)%、(25.34±2.38)%;观察组变化更显著,时间效应Ftime=105.975(P<0.001),干预效应Fintervention=7.378(P=0.008),交互效应Finteraction=3.322(P=0.038)。
- 干预前两组动脉血气参数无显著差异;干预5天后观察组PaO2 100.72±15.75 mmHg vs 对照组93.62±15.54 mmHg(P<0.05),PaCO2 36.53±3.10 mmHg vs 37.69±2.02 mmHg(P<0.05)。
- 干预5天时观察组VIDD发生率15.09%(8/53)显著低于对照组37.25%(19/51),P<0.05。
- 观察组机械通气时间7.93±2.06天 vs 对照组8.77±1.76天,ICU住院时间9.64±2.35天 vs 11.01±2.01天,均P<0.05。
证据类型、等级与局限
- 证据类型:随机对照试验(单中心)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为经皮膈神经电刺激可改善有创机械通气患者的膈肌与呼吸功能,降低VIDD发生率,缩短机械通气时间和ICU住院时间。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the preventive effect of transcutaneous phrenic nerve stimulation on ventilator-induced diaphragmatic dysfunction (VIDD) in patients requiring invasive mechanical ventilation.
METHODS: A randomized controlled trial was conducted. The patients requiring invasive mechanical ventilation admitted to the intensive care unit (ICU) of Jiaxing First Hospital from November 2022 to December 2023 were enrolled. Participants were randomized into the control group and the observation group using a random number table. The control group was given ICU standardized nursing intervention, including turning over and slapping the back, raising the head of the bed, sputum aspiration on demand, aerosol inhalation, oral care, and monitoring of airbag pressure and gastric retention, the observation group was given additional transcutaneous phrenic nerve stimulation intervention on the basis of ICU standardized nursing intervention. The stimulation intensity was set to 10 U, the pulse frequency was set to 40 Hz, and the stimulation frequency was set to 12 times/min. Transcutaneous phrenic nerve stimulation was administered once a day for 30 minutes each time, for a total of 5 days. Diaphragm thickening fraction (DTF) and arterial blood gas parameters on days 1, 3, and 5 of intervention were compared between the two groups. After 5 days of intervention, other parameters including the incidence of VIDD, duration of mechanical ventilation, and length of ICU stay were compared.
RESULTS: A total of 120 patients requiring invasive mechanical ventilation were enrolled, with 16 dropouts (dropout rate was 13.33%). Ultimately, 51 patients in the control group and 53 patients in the observation group were analyzed. Baseline characteristics, including gender, age, body mass index (BMI), acute physiology and chronic health evaluation II (APACHE II) score, albumin (Alb), hemoglobin (Hb), and disease type, showed no significant differences between the two groups. DTF in both groups gradually increased over duration of intervention [DTF on days 1, 3, and 5 in the control group was (20.83±2.33)%, (21.92±1.27)%, and (23.93±2.33)%, respectively, and that in the observation group was (20.89±1.96)%, (22.56±1.64)%, and (25.34±2.38)%, respectively], with more significant changes in DTF in the observation group, showing time effects (Ftime = 105.975, P < 0.001), intervention effects (Fintervention = 7.378, P = 0.008), and interaction effects (Finteraction = 3.322, P = 0.038). Arterial blood gas parameters did not differ significantly before intervention between the groups, but after 5 days of intervention, arterial partial pressure of oxygen (PaO2) in the observation group was significantly higher than that in the control group [mmHg (1 mmHg≈0.133 kPa): 100.72±15.75 vs. 93.62±15.54, P < 0.05], and arterial partial pressure of carbon dioxide (PaCO2) was significantly lower than that in the control group (mmHg: 36.53±3.10 vs. 37.69±2.02, P < 0.05). At 5 days of intervention, the incidence of VIDD in the observation group was significantly lower than that in the control group [15.09% (8/53) vs. 37.25% (19/51), P < 0.05], and both duration of mechanical ventilation and length of ICU stay were significantly shorter than those in the control group [duration of mechanical ventilation (days): 7.93±2.06 vs. 8.77±1.76, length of ICU stay (days): 9.64±2.35 vs. 11.01±2.01, both P < 0.05].
CONCLUSIONS: Transcutaneous phrenic nerve stimulation can improve diaphragmatic and respiratory function in patients receiving invasive mechanical ventilation, reduce the incidence of VIDD, and shorten the duration of mechanical ventilation and length of ICU stay.
参考来源
- Shen Y, Zhang H, Wang L, et al. [Effect of transcutaneous phrenic nerve stimulation in preventing ventilator-induced diaphragmatic dysfunction in invasive mechanically ventilated patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40814706. doi:10.3760/cma.j.cn121430-20240111-00037
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。